Expression of the platelet-activating factor receptor enhances benzyl isothiocyanate-induced apoptosis in murine and human melanoma cells

Sahu,Ravi Prakash

doi:10.3892/mmr.2015.3371

Expression of the platelet-activating factor receptor enhances benzyl isothiocyanate-induced apoptosis in murine and human melanoma cells

Authors:
- Ravi Prakash Sahu
View Affiliations

Affiliations: Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN 46202, USA
Published online on: February 18, 2015 https://doi.org/10.3892/mmr.2015.3371
Pages: 394-400

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Melanoma cells often express platelet‑activating factor receptor (PAF‑R), which has been demonstrated to increase metastatic behavior. However, the effect of PAF‑R on the responsiveness of melanoma to naturally occurring cytotoxic agents remains to be elucidated. The present study aimed to determine the relative cytotoxicity and mechanism of benzyl isothiocyanate (BITC), a component of cruciferous vegetables, in melanoma cells expressing PAF‑R. To evaluate the importance of PAF‑R signaling in melanoma cell growth, PAF‑R‑negative murine B16F10 cells were transduced with a retrovirus containing the cDNA for PAF‑R to generate cells stably expressing PAF‑R (B16‑PAF‑R) or an empty vector (MSCV) to generate PAF‑R‑deficient B16‑MSCV control cells. Activation of PAF‑R, using the PAF‑R agonist, 1‑hexadecyl‑2‑N‑methylcarbamoyl‑3‑glycerophosphocholine, induced an increase in the proliferation of B16‑PAF‑R cells compared with the B16‑MSCV cells. Reverse transcription quantitative polymerase chain reaction revealed the presence of functional PAF‑R in human melanoma SK23MEL cells, but not in SK5MEL cells. The present study investigated the effect of BITC treatments on the survival of murine and human melanoma cells, in the presence or absence of functional PAF‑R. The results revealed that treatment with BITC decreased the survival rate of the PAF‑R‑positive and negative murine and human melanoma cells. However, the expression of PAF‑R substantially augmented BITC‑mediated cytotoxicity in the PAF‑R‑positive cells at lower concentrations compared with the PAF‑R‑negative cells. In order to determine the underlying mechanism, flow cytometric analysis was used, which demonstrated a significant increase in the generation of reactive oxygen species (ROS) in the B16‑PAF‑R cells compared with the B16‑MSCV cells, which enhanced apoptosis by BITC, as measured by increased caspase‑3/7 luminescence. Notably, the BITC‑mediated decreased cell survival rate, increased ROS and increased apoptosis in the B16‑PAF‑R cells were significantly attenuated by the antioxidant, vitamin C, indicating ROS involvement. Additionally, the WEB2086 PAF‑R antagonist, inhibited the BITC‑mediated enhancement of apoptosis in the B16‑PAF‑R cells, indicating a role for PAF‑R‑signaling in the BITC‑mediated effects. These findings indicated that the selectivity of BITC towards PAF‑R in melanoma offers a promising chemopreventive agent for PAF‑R‑positive melanoma treatment.

View Figures

View References

1	Miller AJ and Mihm MC Jr: Melanoma. N Engl J Med. 355:51–65. 2006. View Article : Google Scholar : PubMed/NCBI
2	National Cancer Institute: SEER Stat Fact Sheets: Melanoma of the Skin. http://seer.cancer.gov/statfacts/html/melan.html. Accessed January 21, 2015.
3	Ishii S, Nagase T and Shimizu T: Platelet-activating factor receptor. Prostaglandins Other Lipid Mediat. 68:599–609. 2002. View Article : Google Scholar : PubMed/NCBI
4	Zhuang Q, Bastien Y and Mazer BD: Activation via multiple signaling pathways induces down-regulation of platelet-activating factor receptors on human B lymphocytes. J Immunol. 165:2423–2431. 2000. View Article : Google Scholar : PubMed/NCBI
5	Travers JB, Huff JC, Rola-Pleszczynski M, Gelfand EW, Morelli JG and Murphy RC: Identification of functional platelet-activating factor receptors on human keratinocytes. J Invest Dermatol. 105:816–823. 1995. View Article : Google Scholar : PubMed/NCBI
6	Sahu RP, Kozman AA, Yao Y, DaSilva SC, Rezania S, Martel KC, Warren SJ, Travers JB and Konger RL: Loss of the platelet activating factor receptor in mice augments PMA-induced inflammation and cutaneous chemical carcinogenesis. Carcinogenesis. 33:694–701. 2012. View Article : Google Scholar : PubMed/NCBI
7	Sahu RP, Petrache I, Van Demark MJ, Rashid BM, Ocana JA, Tang Y, Yi Q, Turner MJ, Konger RL and Travers JB: Cigarette smoke exposure inhibits contact hypersensitivity via the generation of platelet-activating factor agonists. J Immunol. 190:2447–2454. 2013. View Article : Google Scholar : PubMed/NCBI
8	Hackler PC, Reuss S, Konger RL, Travers JB and Sahu RP: Systemic platelet-activating factor receptor activation augments experimental lung tumor growth and metastasis. Cancer Growth Metastasis. 19:27–32. 2014.
9	Melnikova VO, Mourad-Zeidan AA, Lev DC and Bar-Eli M: Platelet-activating factor mediates MMP-2 expression and activation via phosphorylation of cAMP-response element-binding protein and contributes to melanoma metastasis. J Biol Chem. 281:2911–2922. 2006. View Article : Google Scholar
10	Heon Seo K, Ko HM, Kim HA, Choi JH, Jun Park S, Kim KJ, Lee HK and Im SY: Platelet-activating factor induces upregulation of antiapoptotic factors in a melanoma cell line through nuclear factor-kappaB activation. Cancer Res. 66:4681–4686. 2006. View Article : Google Scholar : PubMed/NCBI
11	Biancone L, Cantaluppi V, Del Sorbo L, Russo S, Tjoelker LW and Camussi G: Platelet-activating factor inactivation by local expression of platelet-activating factor acetyl-hydrolase modifies tumor vascularization and growth. Clin Cancer Res. 9:4214–4220. 2003.PubMed/NCBI
12	de Oliveira SI, Andrade LN, Onuchic AC, Nonogaki S, Fernandes PD, Pinheiro MC, Rohde CB, Chammas R and Jancar S: Platelet-activating factor receptor (PAF-R)-dependent pathways control tumour growth and tumour response to chemotherapy. BMC Cancer. 10:2002010. View Article : Google Scholar : PubMed/NCBI
13	Sahu RP, Turner MJ, DaSilva SC, Rashid BM, Ocana JA, Perkins SM, Konger RL, Touloukian CE, Kaplan MH and Travers JB: The environmental stressor ultraviolet B radiation inhibits murine antitumor immunity through its ability to generate platelet-activating factor agonists. Carcinogenesis. 33:1360–1367. 2012. View Article : Google Scholar : PubMed/NCBI
14	Barber LA, Spandau DF, Rathman SC, Murphy RC, Johnson CA, Kelley SW, Hurwitz SA and Travers JB: Expression of the platelet-activating factor receptor results in enhanced ultraviolet B radiation-induced apoptosis in a human epidermal cell line. J Biol Chem. 273:18891–18897. 1998. View Article : Google Scholar : PubMed/NCBI
15	Li T, Southall MD, Yi Q, Pei Y, Lewis D, Al-Hassani M, Spandau D and Travers JB: The epidermal platelet-activating factor receptor augments chemotherapy-induced apoptosis in human carcinoma cell lines. J Biol Chem. 278:16614–16621. 2003. View Article : Google Scholar : PubMed/NCBI
16	Jilaveanu LB, Aziz SA and Kluger HM: Chemotherapy and biologic therapies for melanoma: Do they work? Clin Dermatol. 27:614–625. 2009. View Article : Google Scholar : PubMed/NCBI
17	Block G, Patterson B and Subar A: Fruit, vegetables and cancer prevention: A review of the epidemiological evidence. Nutr Cancer. 18:1–29. 1992. View Article : Google Scholar
18	Stoner GD and Morse MA: Isothiocyanates and plant polyphenols as inhibitors of lung and esophageal cancer. Cancer Lett. 114:113–119. 1997. View Article : Google Scholar : PubMed/NCBI
19	Sahu RP and Srivastava SK: The role of STAT-3 in the induction of apoptosis in pancreatic cancer cells by benzyl isothiocyanate. J Natl Cancer Inst. 101:176–193. 2009. View Article : Google Scholar : PubMed/NCBI
20	Warin R, Xiao D, Arlotti JA, Bommareddy A and Singh SV: Inhibition of human breast cancer xenograft growth by cruciferous vegetable constituent benzyl isothiocyanate. Mol Carcinog. 49:500–507. 2010. View Article : Google Scholar : PubMed/NCBI
21	Wu CL, Huang AC, Yang JS, Liao CL, Lu HF, Chou ST, Ma CY, Hsia TC, Ko YC and Chung JG: Benzyl isothiocyanate (BITC) and phenethyl isothiocyanate (PEITC)-mediated generation of reactive oxygen species causes cell cycle arrest and induces apoptosis via activation of caspase-3, mitochondria dysfunction and nitric oxide (NO) in human osteogenic sarcoma U-2 OS cells. J Orthop Res. 29:1199–1209. 2011. View Article : Google Scholar : PubMed/NCBI
22	Wu X, Zhu Y, Yan H, Liu B, Li Y, Zhou Q and Xu K: Isothiocyanates induce oxidative stress and suppress the metastasis potential of human non-small cell lung cancer cells. BMC Cancer. 10:2692010. View Article : Google Scholar : PubMed/NCBI
23	Ni WY, Hsiao YP, Hsu SC, Hsueh SC, Chang CH, Ji BC, Yang JS, Lu HF and Chung JG: Oral administration of benzyl-isothiocyanate inhibits in vivo growth of subcutaneous xenograft tumors of human malignant melanoma A375.S2 cells. In Vivo. 27:623–626. 2013.PubMed/NCBI
24	Huang SH, Wu LW, Huang AC, Yu CC, Lien JC, Huang YP, Yang JS, Yang JH, Hsiao YP, Wood WG, Yu CS and Chung JG: Benzyl isothiocyanate (BITC) induces G2/M phase arrest and apoptosis in human melanoma A375.S2 cells through reactive oxygen species (ROS) and both mitochondria-dependent and death receptor-mediated multiple signaling pathways. J Agric Food Chem. 60:665–675. 2012. View Article : Google Scholar
25	Thejass P and Kuttan G: Allyl isothiocyanate (AITC) and phenyl isothiocyanate (PITC) inhibit tumour-specific angiogenesis by downregulating nitric oxide (NO) and tumour necrosis factor-alpha (TNF-alpha) production. Nitric Oxide. 16:247–257. 2007. View Article : Google Scholar
26	Manesh C and Kuttan G: Effect of naturally occurring allyl and phenyl isothiocyanates in the inhibition of experimental pulmonary metastasis induced by B16F-10 melanoma cells. Fitoterapia. 74:355–363. 2003. View Article : Google Scholar : PubMed/NCBI
27	Hamsa TP, Thejass P and Kuttan G: Induction of apoptosis by sulforaphane in highly metastatic B16F-10 melanoma cells. Drug Chem Toxicol. 34:332–340. 2011. View Article : Google Scholar : PubMed/NCBI
28	Sahu RP, DaSilva SC, Rashid B, Martel KC, Jernigan D, Mehta SR, Mohamed DR, Rezania S, Bradish JR, Armstrong AB, Warren S and Konger RL: Mice lacking epidermal PPARγ exhibit a marked augmentation in photocarcinogenesis associated with increased UVB-induced apoptosis, inflammation and barrier dysfunction. Int J Cancer. 131:E1055–E1066. 2012. View Article : Google Scholar : PubMed/NCBI
29	Sharma A, Sharma AK, Madhunapantula SV, Desai D, Huh SJ, Mosca P, Amin S and Robertson GP: Targeting Akt3 signaling in malignant melanoma using isoselenocyanates. Clin Cancer Res. 15:1674–1685. 2009. View Article : Google Scholar : PubMed/NCBI
30	Sahu RP, Zhang R, Batra S, Shi Y and Srivastava SK: Benzyl isothiocyanate-mediated generation of reactive oxygen species causes cell cycle arrest and induces apoptosis via activation of MAPK in human pancreatic cancer cells. Carcinogenesis. 30:1744–1753. 2009. View Article : Google Scholar : PubMed/NCBI
31	Xiao D, Powolny AA and Singh SV: Benzyl isothiocyanate targets mitochondrial respiratory chain to trigger reactive oxygen species-dependent apoptosis in human breast cancer cells. J Biol Chem. 283:30151–30163. 2008. View Article : Google Scholar : PubMed/NCBI
32	Miyoshi N, Watanabe E, Osawa T, Okuhira M, Murata Y, Ohshima H and Nakamura Y: ATP depletion alters the mode of cell death induced by benzyl isothiocyanate. Biochim Biophys Acta. 1782:566–573. 2008. View Article : Google Scholar : PubMed/NCBI
33	Doroshow JH: Redox modulation of chemotherapy-induced tumor cell killing and normal tissue toxicity. J Natl Cancer Inst. 98:223–235. 2006. View Article : Google Scholar : PubMed/NCBI
34	Huang CS, Lin AH, Liu CT, Tsai CW, Chang IS, Chen HW and Lii CK: Isothiocyanates protect against oxidized LDL-induced endothelial dysfunction by upregulating Nrf2-dependent antioxidation and suppressing NFκB activation. Mol Nutr Food Res. 57:1918–1930. 2013. View Article : Google Scholar : PubMed/NCBI
35	Miyoshi N, Takabayashi S, Osawa T and Nakamura Y: Benzyl isothiocyanate inhibits excessive superoxide generation in inflammatory leukocytes: implication for prevention against inflammation-related carcinogenesis. Carcinogenesis. 25:567–575. 2004. View Article : Google Scholar
36	Marques SA, Dy LC, Southall MD, Yi Q, Smietana E, Kapur R, Marques M, Travers JB and Spandau DF: The platelet-activating factor receptor activates the extracellular signal-regulated kinase mitogen-activated protein kinase and induces proliferation of epidermal cells through an epidermal growth factor-receptor-dependent pathway. J Pharmacol Exp Ther. 300:1026–1035. 2002. View Article : Google Scholar : PubMed/NCBI
37	Brandmaier AG, Leitner WW, Ha SP, Sidney J, Restifo NP and Touloukian CE: High-avidity autoreactive CD4+ T cells induce host CTL, overcome T(regs) and mediate tumor destruction. J Immunother. 32:677–688. 2009. View Article : Google Scholar : PubMed/NCBI